AstraZeneca
The Global Head, ESE—CVRM at AstraZeneca leads the external scientific engagement strategy for the Cardiovascular, Renal & Metabolism therapeutic area, representing the TA externally and advancing scientific leadership. This role shapes partnerships, guideline adoption, and evidence generation to accelerate standards of care while aligning Medical, R&D, and Commercial stakeholders globally.
Headquarters
Cambridge, England, United Kingdom
Company Size
10001+ employees
Founded
1999
Digital Biology is part of AstraZeneca, a global biopharmaceutical company focused on discovering, developing, and commercializing prescription medicines. The Digital Biology organization applies data science, computational biology, AI, and software engineering to accelerate drug discovery and translational research across therapeutic areas.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AstraZeneca.
Vice President Cardiovascular, Renal & Metabolism (Genentech Research and Early Development)
Roche
Regional Medical Scientific Director (Medical Science Liaison) - Cardiovascular & Metabolism - MI & Northern Ohio
MSD
Director, Strategic Alliances & External Engagement – Medical Affairs
Mineralys Therapeutics
Key Account Partner CVRM (Bydgoszcz, Tuchola, Sępólno Krajeńskie, Świecie)
American Association of Physicists in Medicine
Director of Scientific Affairs
KOB Solutions, Inc.
CV Therapeutic Area Lead
Amgen